FDA Approves Novartis Malaria Treatment
The FDA recently reported clinical studies showing that Coartem, a Novartis malaria drug, was safe and effective at treating one type of the disease. The drug already has been approved for use in more than 80 countries.
Read more about critical R&D contributions in the fight to end malaria 
The global fight against HIV/AIDS, TB and malaria requires the most effective tools possible—the best antiretrovirals, the fastest TB tests and the longest-lasting bed nets.
Read MoreMember Profiles
Business Action Magazine
In-depth Articles
Resource Hub
Events
- Jun. 1 - 2, 20112011 Conference and Awards Dinner
- Oct. 31, 2011South Africa: Rural and Urban Business Action on Health
- Sep. 10, 20102nd Wellness at Work members’ Workshop
